For patients with treatment-resistant hypertension and chronic kidney disease, renal denervation (RDN) reduces blood pressure (BP) and can slow renal function decline.
Drinking caffeinated coffee correlates with improved microvascular endothelial function.
For former light smokers who quit ≤15 years ago, the risks of incident heart failure or cardiovascular mortality are not significantly increased.
Cardiovascular fitness has declined substantially among children and youth around the world since the 1960s.
Hospitalizations for atrial fibrillation are projected to increase by 28% in the next decade, while costs are projected to increase by 55%.
More than half of men with sudden cardiac arrest (SCA) experience symptoms, usually in the previous four weeks.
Vaccines may provide solutions for high blood pressure and cholesterol control.
According to data from the Trial to Assess Chelation Therapy (TACT), chelation treatments reduced cardiovascular events (eg, heart attack, death) in patients with diabetes but not in those without diabetes.
According to results from a National Institutes of Health-funded study, a commonly used stenting procedure in the renal artery appears to offer no significant improvement when added to medication-based therapy.